Showing results (1011-1020 of 1,033) with videos related to

Sort By:
Pageof 104
The Lancet. Respiratory Medicine|January 18, 2024
Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trialZhe Wu, Lisa G Spencer, Winston Banya, et al.
The Lancet. Respiratory Medicine|August 29, 2024
Evaluation of elexacaftor-tezacaftor-ivacaftor treatment in individuals with cystic fibrosis and CFTRN1303K in the USA: a prospective, multicentre, open-label, single-arm trialGeorge M Solomon, Rachel W Linnemann, Rachel Rich, et al.
The Lancet. Respiratory Medicine|September 13, 2024
Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory studyYongfeng Yu, Qisen Guo, Yongchang Zhang, et al.
The Lancet. Respiratory Medicine|September 12, 2024
Respiratory syncytial virus infections in adults: a narrative reviewJoanne G Wildenbeest, David M Lowe, Joseph F Standing, et al.
The Lancet. Respiratory Medicine|October 4, 2024
Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, non-inferiority trialRuth L Goodall, Andrew J Nunn, Sarah K Meredith, et al.
The Lancet. Respiratory Medicine|August 10, 2024
Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance studyMargaux M I Meslé, Jeremy Brown, Piers Mook, et al.
The Lancet. Respiratory Medicine|July 26, 2024
Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 studyJin-Ji Yang, Jianying Zhou, Si-Yang Maggie Liu, et al.
The Lancet. Respiratory Medicine|May 18, 2025
General population-based lung function trajectories over the life course: an accelerated cohort studyJudith Garcia-Aymerich, Martí de Las Heras, Anne-Elie Carsin, et al.
The Lancet. Respiratory Medicine|April 18, 2025
Evidence-based personalised medicine in critical care: a framework for quantifying and applying individualised treatment effects in patients who are critically illElizabeth S Munroe, Alexandra Spicer, Andrea Castellvi-Font, et al.
The Lancet. Respiratory Medicine|March 28, 2025
Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trialNan-Shan Zhong, Rong Qiu, Jie Cao, et al.
Pageof 104